Marino Garcia

Marino Garcia

Chief Executive Officer at DIANTHUS THERAPEUTICS, INC.

Net worth: - $ as of 2024-04-29

57 year
Health Technology
Consumer Services

Profile

Marino Garcia is currently the President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. and Dianthus Therapeutics, Inc. He previously worked as the Vice President-Business Development at Aptalis Pharma Canada ULC from 2010 to 2014, Vice President-US Commercial Operations at Aspreva Pharmaceuticals Corp.
from 2006 to 2010, Senior VP-Corporate & Business Development at Zealand Pharma A from 2018 to 2021, and Chief Strategy Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2016 to 2018.
Mr. Garcia completed his undergraduate degree at Concordia University and his MBA at Richard Ivey School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-31 0 ( -.--% ) - $ 2024-04-29

Marino Garcia active positions

CompaniesPositionStart
DIANTHUS THERAPEUTICS, INC. Chief Executive Officer 2023-09-10
Chief Executive Officer 2021-10-31
All active positions of Marino Garcia

Former positions of Marino Garcia

CompaniesPositionEnd
ZEALAND PHARMA A/S Corporate Officer/Principal 2021-09-30
SYNERGY PHARMACEUTICALS INC Corporate Officer/Principal 2018-09-29
Corporate Officer/Principal 2014-03-12
Corporate Officer/Principal 2009-12-31
See the detail of Marino Garcia's experience

Training of Marino Garcia

Concordia University Undergraduate Degree
Richard Ivey School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marino Garcia's experience

Connections

77

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ZEALAND PHARMA A/S

Health Technology

DIANTHUS THERAPEUTICS, INC.

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW